Concepedia

Ping Jiang

PJ

61

Publications

4.1K

Citations

30

H-Index

1994

Active since

Affiliations

AbbVie (United States)(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Fred Hutch Cancer Center

University of Washington

Halozyme Therapeutics (United States)

Ping Jiang is an author at AbbVie (United States) specializing in medicine, pharmacology, and cancer research.

ORCID

Top concepts

Publications per year

1994–2022

61

Publications

61

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Clifford J. Whatcott, Caroline H. Diep, Ping Jiang et al. · Clinical Cancer Research · 2015 · 605 citations · Full text

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock et al. · Journal of Clinical Oncology · 2017 · 467 citations

, , +17

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer

Sunil R. Hingorani, William Proctor Harris, J. Thaddeus Beck et al. · Clinical Cancer Research · 2016 · 317 citations · Full text

PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Helen Y. Zou, Qiuhua Li, Lars D. Engstrom et al. · Proceedings of the National Academy of Sciences · 2015 · 267 citations · Full text

, , +14

A fluorescent orthotopic bone metastasis model of human prostate cancer.

Meng Yang, Ping Jiang, F X Sun et al. · PubMed · 1999 · 194 citations

, , +15

Rows per page

1–5 of 61